Perthera's Unattributed - II Round

Perthera raised a round of funding on December 26, 2017.

Personalized Cancer Therapy, dba Perthera, is the market and technology leader in developing Precision Cancer Analysis ("PCA") used to provide detailed molecular information about cancer tumors. The …

Articles about Perthera's Unattributed - II Round: